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Abstract: The renal collecting duct fine-tunes urinary composition, and thereby, coordinates key
physiological processes, such as volume/blood pressure regulation, electrolyte-free water reabsorption,
and acid-base homeostasis. The collecting duct epithelium is comprised of a tight epithelial barrier
resulting in a strict separation of intraluminal urine and the interstitium. Tight junctions are
key players in enforcing this barrier and in regulating paracellular transport of solutes across the
epithelium. The features of tight junctions across different epithelia are strongly determined by
their molecular composition. Claudins are particularly important structural components of tight
junctions because they confer barrier and transport properties. In the collecting duct, a specific set of
claudins (Cldn-3, Cldn-4, Cldn-7, Cldn-8) is expressed, and each of these claudins has been implicated
in mediating aspects of the specific properties of its tight junction. The functional disruption of
individual claudins or of the overall barrier function results in defects of blood pressure and water
homeostasis. In this concise review, we provide an overview of the current knowledge on the role of
the collecting duct epithelial barrier and of claudins in collecting duct function and pathophysiology.
Keywords: epithelial barrier; barrier formation; collecting duct; tight junction; claudin
1. Introduction
Selective barriers formed by epithelial monolayers are vital for many critical physiological
processes [1]. These barriers are composed of intercellular multiprotein complexes along the apical-basal
axis of epithelial cells creating direct cell-cell interactions and forming apical junctional complexes [2].
These complexes include tight junctions (TJs), adherens junctions, and desmosomes.
TJs are the most apical and diverse of these junctional complexes. They are formed by
transmembrane as well as cytoplasmic proteins and are linked to the cytoskeleton. The protein
composition of TJs varies greatly among different epithelia and determines the barrier properties and
permeability [3].
Overall, TJs serve a dual function in epithelial layers acting as (a) a fence, separating membrane
proteins between the apical and basolateral membrane and (b) as a gate by regulating size- and
charge-selective movements of ions, solutes, and small molecules via the paracellular route [4–7].
Consequently, TJs are not only critical to establish and maintain cell adhesion and epithelial polarity
but are also necessary to create selective paracellular permeability between compartments.
Several studies show that the main protein family mediating TJ characteristics and functions are
the membrane-spanning claudins. So far, more than 25 different claudins have been identified, and
at least 10 of them are expressed in spatiotemporal patterns along the renal nephron (for a detailed
review see [8]).
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Structurally, the transmembrane proteins connect in both cis and trans to neighboring claudins of
the same, as well as the opposing, cell membranes forming TJ strands [9]. Claudins are sufficient to
arrange those strands when expressed in cells lacking endogenous TJ formation [10].
Here, we review the role of claudins in epithelial barrier formation with emphasis on the renal
collecting duct as well as their implications in collecting duct physiology and function.
2. The Renal Collecting Duct
The renal collecting duct is the most distal part of the renal tubules. It connects renal nephrons
with the renal pelvis and—together with the distal convoluted tubule and the connecting tubule—it
contributes to the aldosterone-sensitive distal nephron. In general, the renal collecting duct plays
important roles in fine-tuning urinary composition, extracellular fluid volume, electrolyte balance,
blood pressure regulation, water homeostasis, and acid-base regulation [11,12].
Although most of the water and solute reabsorption in the kidney occurs in the more upstream
segments of the nephron, transport variability in the renal collecting duct is significantly higher, and
ion and water transport are under strict hormonal control [11]. This permits to adjust reabsorption
and secretion to prevalent physiological conditions and to control the body’s water and electrolyte
balance closely.
The main solutes reabsorbed in the collecting duct are sodium (Na+) and chloride (Cl−), while
potassium (K+) is secreted into the urine [13] (Figure 1). Transport of these ions occurs via the
transcellular route—mediated by channels and membrane transporters—and via the paracellular
route—mediated by TJs.
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Figure 1. Transport in the renal collecting duct. In the renal collecting duct Na+ and Cl− are reabsorbed,
while K+ is secreted into the urine. A steep osmolality gradient between the interstitium and lumen
across the epithelial barrier is the driving force for water reabsorption.
3. Claudins and Their Roles in Collecting Duct Epithelial Barrier Formation and Paracellular
Ion Transport
In general, claudins can be pore- or barrier-forming [14]. As in other segments of the renal nephron,
it is believed that the expressed claudins are the main mediators of TJ permeability characteristics,
and thus control the paracellular pathway in the collecting duct [9,15]. Am ng the predo inatel
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expressed claudins in the renal collecting duct are claudin-3 (Cldn-3), -4 (Cldn-4), -7 (Cldn-7) and -8
(Cldn-8) [16,17]. Furthermore, a recently published study proposes a role for claudin-19 (Cldn-19) in
the renal collecting duct [18]. Overall, the present knowledge strongly supports the theory that these
claudins either enforce the epithelial barrier in general or build a paracellular Cl− channel, while other
aspects of their functions are less clear (Table 1).
Table 1. Claudins expressed in the renal collecting duct and their proposed function in barrier formation
and collecting duct tight junctions.
Claudin Proposed Function in theCollecting Duct Tight Junction Knockout Phenotype In Vivo
Cldn-3 General barrier function [19,20] Increase in urinary pH, no electrolyte abnormalities [21]
Cldn-4 Cl− channel, cation barrier [22] Hypotension, hypochloremia, metabolic alkalosis, renalwasting of Na+ and Cl− [23]
Cldn-7 Cl− and Na+ channel [24–27] Severe renal salt wasting, dehydration [27]
Cldn-8 Cl− channel, cation barrier [28,29] Hypotension, hypochloremia, metabolic alkalosis, renalwasting of Na+ and Cl− [29]
Cldn-19 Adaption of barrier selectivity toosmolality [18] -
In the following sections, we will briefly review the published literature on the functions of these
claudins in the collecting duct. As a general note, it should be acknowledged that gain-of-function
studies utilizing overexpression of claudins in cell lines have a general limitation due to the influence of
the endogenous components of the TJ in each cell line. The expressed claudins in the respective chosen
model make it difficult to determine the exact impact of single claudins on permeability characteristics.
In contrast, loss-of-function studies, if carried out in the appropriate system (i.e., the collecting duct
in vivo or cell lines that accurately represent collecting duct epithelia), are more appropriate to outline
the molecular functions of each claudin.
3.1. Cldn-3
Several studies have found that Cldn-3 enforces the paracellular barrier [19,20]. Its overexpression
in otherwise leaky Madin-Darby Canine Kidney (MDCK) II cells leads to an altered TJ structure with
increased transepithelial resistance (TER) and decreased permeability for ions as well as molecules
of 332 Da and 4 kDa, indicating a general role for Cldn-3 in barrier formation and enforcement [19].
Furthermore, Cldn-3 has been described to promote tubule formation in vitro and might thus play a
role during tubule morphogenesis in the developing kidney [30]. The conditional knockout of Cldn-3
resulted in increased urinary pH without any effect on urine or plasma electrolytes [21]. However, the
collecting duct-specific role of Cldn-3 has not been studied so far.
3.2. Cldn-7
Cldn-7-deficient mice die shortly after birth due to severe renal salt wasting and dehydration [27].
Interestingly, collecting duct cells isolated from Cldn-7-deficient mice demonstrate an increase in TER
and show decreased paracellular permeability for both Na+ and Cl− [31]. This suggests that Cldn-7
may form a non-selective paracellular channel facilitating Cl− and Na+ reabsorption in collecting ducts.
Different and partially conflicting roles of Cldn-7 have been suggested in other experimental
systems, complicating the interpretation of Cldn-7 biology. Overexpression of Cldn-7 in LLC-PK1 cells
induces an increase in TER accompanied by a reduced Cl− and elevated Na+ conductance [24]. In
contrast, the knockdown of Cldn-7 in those cells leads to loss of anion selectivity and decreased Cl−
permeation, whereas in cation-selective MDCK cells, knockdown of Cldn-7 leads to increased Na+
permeability [25]. Mutation experiments in vitro demonstrated the importance of specific negatively
charged amino acids in the extracellular loop of Cldn-7 for paracellular permeability and charge
Int. J. Mol. Sci. 2020, 21, 221 4 of 11
selectivity [32]. These contrasting results could indicate different roles for Cldn-7, depending on the
cellular background, and endogenously expressed TJ components.
3.3. Cldn-4 and Cldn-8
Both, Cldn-4 and Cldn-8, are thought to serve as a cation barrier [33–35] and an anion channel [22].
This hypothesis is supported by data from in vivo experiments. Collecting duct-specific knockout of
either Cldn-4 or Cldn-8, causes hypotension, hypochloremia, metabolic alkalosis and renal wasting
of Na+ and Cl− [23,29]. These phenotypes would be consistent with Cldn-4 and Cldn-8 acting as
paracellular Cl− channels, which are necessary for a paracellular “chloride shunt” required for effective
transcellular Na+ reabsorption (via the epithelial sodium channel).
Different effects of Cldn-4 overexpression on charge selectivity, depending on the used cell model,
have been described. Overexpression of Cldn-4 leads to an increase in TER in cation-selective MDCK
II and anion-selective LLC-PK1 cells, but a decrease in Na+ permeability is only observed in MDCK II
cells [34].
Cldn-8 has been shown to be necessary to recruit Cldn-4 to the TJ and to implement the protein
into the junctional complex. In the absence of Cldn-8, Cldn-4 is mainly found in the endoplasmic
reticulum and the Golgi complex, but not in the apical cell membrane where TJs are located [22]. Thus,
Cldn-8 knockout causes a functional double knockout on the TJ level due to its requirement for correct
Cldn-4 localization [22].
3.4. Cldn-19
In addition to the longer known claudins of the renal collecting duct described above, a recently
published study indicates a role for Cldn-19, which had previously been linked to thick ascending
limb functions [36–38]. Cldn-19 is associated with tightness and cation selectivity of the epithelial
barrier. Interestingly, the TJ localization of Cldn-19 is promoted by a low osmolality, whereas high
osmolality favors an intracellular localization, suggesting that it may contribute to tonicity-induced
changes in paracellular ion selectivity [18]. This role of a claudin in epithelial adaption to the changing
osmolality along the corticomedullary axis provides an interesting aspect of TJ physiology but collecting
duct-specific knockout models of Cldn-19 have not yet been generated.
4. The Collecting Duct Epithelial Barrier in Electrolyte-Free Water Reabsorption
Although water transport in the renal collecting duct is not directly facilitated by water
channel-forming claudins (contrasting with observations of Cldn-2 in the proximal tubule [39]),
TJs in the collecting duct contribute to water reabsorption indirectly.
The driving force for water reabsorption in the renal collecting duct is a steep osmolality gradient
formed by high concentrations of osmolytes in the interstitium, which increases towards the renal
medulla [40]. The tight collecting duct epithelial barrier is crucial to maintain the osmolality gradient
between the tubular lumen and the interstitium.
Water transport in the renal collecting duct is mainly controlled by arginine vasopressin (AVP),
also called antidiuretic hormone. If the water content in the body is low, AVP binds to its type 2
receptor (V2R) localized in the basal cell membrane of collecting duct principal cells and stimulates
the expression of aquaporin-2 (AQP2) water channels. Furthermore, AVP triggers a signaling cascade
leading to the accumulation of AQP2 in the apical membrane (for a detailed review see [11,41]). This
mechanism enables reabsorption of electrolyte-free water from the intraluminal urine and forms the
basis of urinary concentrating ability. Inactivation of either V2R or AQP2 leads to polyuria with
massive excretion of electrolyte-free water, a condition called nephrogenic diabetes insipidus [42].
A recent study has demonstrated the importance of an intact epithelial barrier in the renal collecting
duct for efficient water reabsorption [43]. Deletion of the transcriptional regulator Grainyhead-like 2
(Grhl2), an epithelial transcription factor that induces the expression of barrier-enforcing molecular
TJ components including Cldn-4 [44], results in a leaky collecting duct epithelium and a decreased
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TER across the collecting duct epithelium. Leakage of interstitial osmolytes across the Grhl2-deficient
collecting duct epithelium is associated with defective retention of osmolytes in the interstitium of
the inner medulla. Grhl2-deficient mice show signs of diabetes insipidus and fail to concentrate
their urine adequately, although AQP-mediated water transport across the apical and basolateral
membranes of Grhl2-deficient collecting ducts is intact [43]. This indicates that a tight collecting duct
epithelial barrier is crucial for the maintenance of osmolality gradients and for effective collecting duct
water reabsorption. Interestingly, Grhl2 deficiency (unlike deficiencies of individual claudins) was not
associated with abnormalities of Cl− and Na+ reabsorption. It needs to be acknowledged that Grhl2
functions are not restricted to the effects on the TJ, which may explain the difference in phenotypes. In
addition, it is possible that the barrier defect of Grhl2-deficient collecting duct cells is more profound,
leading to non-ion-selective leakage of interstitial osmolytes into hypotonic urine.
5. Aldosterone and Its Role in Transcellular and Paracellular Transport Regulation
In the renal collecting duct, Na+ transport is separated from Cl− transport [45]. Na+ reabsorption
from the intraluminal urine occurs transcellularly via the epithelial sodium channel (ENaC) that locates
to the apical membrane of collecting duct principal cells. This generates a lumen-negative potential,
providing a driving force for K+ secretion via the renal outer medullary potassium channel (ROMK).
In contrast, Cl− reabsorption in the collecting duct occurs predominantly via the paracellular route.
This “chloride shunt” is important to limit the built-up of a lumen-negative potential and, thereby,
facilitates continued Na+ reabsorption and prevents excessive K+ secretion.
The key regulator of ENaC is aldosterone, a hormone secreted from the adrenal gland in response
to hyperkalemia and hypovolemia [11,46]. Overall, aldosterone plays a central role in blood pressure
regulation by controlling plasma Na+ and K+ levels and thus indirectly influences water retention or
loss. However, growing evidence supports the hypothesis that aldosterone controls Na+ reabsorption
and K+ secretion not only by regulating the abundance of ENaC and increasing transcellular transport
but also by adjusting paracellular Cl− permeability in multiple ways:
For instance, aldosterone triggers the expression of Cldn-8 when ENaC is active, presumably to
seal the paracellular route for Na+ back flux. Thereby net flux of Na+ can be increased [28].
Additionally, aldosterone regulates channel-activating protease 1 (Cap1) [47]. Cap1, in
turn, stimulates ENaC and inhibits the Cl− conductivity by directly regulating Cldn-4
trans-interactions [23,48]. Thereby K+ secretion is favored over Cl− reabsorption (Figure 2a).
Aldosterone also induces the phosphorylation and activation of the with no lysine kinases 4
(WNK4) [49]. Expression of WNK4 in MDCK II cells has been shown to reduce the TER and increase
Cl− permeability, without affecting TJ structure [50]. Activated WNK4 phosphorylates Cldn-4 on
threonine residues decreasing the cells’ TER and increasing apical to basal anion passage [51].
In the absence of aldosterone, WNK4 inhibits ENaC and ROMK activity and thus directly
opposes Cap1 [52,53]. WNK4 phosphorylation suspends this inhibition (Figure 2b). Taken together,
this indicates the possibility that aldosterone might regulate claudins through Cap1 and WNK4,
coordinating Cl− reabsorption or K+ secretion, respectively.
Kahle and colleagues proposed WNK4 as the functional switch regulating Na+ and Cl−
reabsorption independently from K+ secretion depending on the physiological conditions [53].
However, the factors facilitating different functional states of WNK4 haven’t been provided, and to our
knowledge, it is still unknown how the reverse actions of Cap1 and WNK4, that are both mediated by
aldosterone, are regulated to decide in favor of K+ secretion or Cl− reabsorption, respectively.
In diabetes, the role of aberrant aldosterone signaling in the progression of renal disease has
long been established [54,55]. Mediated by the divergent aldosterone levels, Cldn-4 and Cldn-8 are
overexpressed in the distal nephron from type 1 diabetic rats, and the expression of WNK4 and its
co-localization with Cldn-4 and Cldn-8 is also increased [56,57]. This might result in increased activation
of Cldn-4 and Cldn-8 by WNK4 under diabetic conditions and could implicate disturbed paracellular
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Figure 2. (a) Aldosterone-mediated induction of channel-activating protease 1 (Cap1) activates Na+
reabsorption, but simultaneously inhibits the paracellular “chloride shunt”, resulting in excessive K+
excretion. When aldosterone is secreted (1), it triggers the expression of Cap1 in principal cells of
the renal collecting duct (2). Cap1 inhibits Cl− reabsorption directly by disrupting trans-interactions
of Cldn-4. Simultaneously, Cap1 activates apical Na+ channels (ENaC), and thus, increases the
transcellular reabsorption of Na+ (3). Consequently, the growing luminal negative potential drives K+
secretion into the urine via renal outer medullary potassium (ROMK) channels (4). (b) Aldosterone
activates ENaC, ROMK, and the paracellular “chloride shunt” via with no lysine kinases 4 (WNK4)
phosphorylation. When aldosterone is secreted (1), it leads to the phosphorylation of WNK4. This
suspends the tonic inhibition of ROMK and ENaC by WNK4 (2). Furthermore, WNK4 phosphorylates
claudins located to the tight junctions (TJs) of the renal collecting duct and thereby increases Cl−
reabsorption (3). Green arrows indicate positive regulation, red lines indicate inhibition.
6. Chloride Reabsorption in Renal Collecting Ducts and Potential Involvement in Disease
The aldosterone-sensitive distal nephron is the main side of Cl− reabsorption. It occurs via
multiple ways, including paracellular transport via TJs as well as transcellular pathways in intercalated
cells [12,23,29] and is driven by the lumen-negative transepithelial potential generated by the unilateral
Na+ reabsorption to maintain electroneutrality (Figure 3). As in aldosterone signaling, it becomes
increasingly evident that crosstalk between paracellular and transcellular transport occurs.
The importance of efficient Cl− reabsorption becomes obvious in claudin-deficient mouse models.
For example, Cldn-7 deficiency in mice is lethal within 12 days after birth due to severe salt-wasting
and subsequent chronic dehydration (see above) [27]. Cldn-7−/− mice show reduced ROMK and
increased ENaC, Aqp2, and Na+ Cl− cotransporter mRNA. These changes in channel expressions are
probably due to a compensatory mechanism to inhibit further urinary loss of salt and water [27].
It has long been established that accumulation of luminal Cl− depolarizes the membrane,
and thereby, inhibits the apical Na+ channel ENaC [58]. Several studies also have demonstrated
that pathological increases in Cl− reabsorption are associated with diseases, such as
pseudo-hypoaldosteronism type II (PHA-II) or Gordon’s syndrome.
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PHA-II is a rare Mendelian syndrome leading to hypertension, hyperkalemia, and metabolic
acidosis [59]. These symptoms are the exact opposite of the Cldn-4 and Cldn-8 knockout phenotypes
in mice [23,29].
Interestingly, a long-known causative gene for PHA-II is WNK4 [60], and WNK4 can regulate Cl−
conductance presumably by phosphorylation of Cldn-4 and Cldn-8 [50]. The PHA-II-causing mutation
of WNK4 increases paracellular Cl− permeability in vitro [49,50]. Consistent with the proposed Cl−
pore activity of Cldn-4 and Cldn-8, this is an additional indicator of an activating effect of claudin
phosphorylation by WNK4. Furthermore, a recent study demonstrates that WNK4 is overexpressed
in Cldn-7-deficient cultured, collecting duct cells [31]. Conversely, the PHA-II mutant of WNK4 is
associated with increased Cldn-7 phosphorylation and enhanced paracellular Cl− conductivity [26].
This adds a new aspect and raises the possibility that claudins might act both up- and down-stream of
WNK4 to regulate paracellular transport.
Another gene associated with PHA-II is KLHL3, encoding Kelch-like protein 3 [61,62]. Interestingly,
KLHL3 normally induces ubiquitination and degradation of Cldn-8, while disease-associated mutations
of KLHL3 abolish the interaction of KLHL3 with Cldn-8 [29]. In addition, KLHL3 leads to the
ubiquitination of WNK4. In line with PHA-II symptoms, loss of KLHL3 increases Cl- permeability
in vivo [29], which may contribute to the disease phenotype.
7. Conclu ions
Collecting duct epithelia express claudins enforcing a high TER such as Cldn-3, -4, -7, -8, and -19,
consistent with a demand for strong epithelial barrier function in the presence of steep transepithelial
gradients. Based on our current knowledge, these claudins are thought to either support a tight barrier
in general or to act as a cation barrier and/or an anion channel.
Consequently, the renal collecting duct is comprised of an especially tight epithelial barrier
compared to other, more upstream segments of the nephron. As a result, the collecting duct lumen
and interstitium are strictly separated. Nevertheless, the TJs of the collecting duct exhibit a regulated
paracellular permeability for ions such as Cl-. Hence, the collecting duct TJ participates in a range of
physiological functions:
It allows for controlled paracellular transport of Cl- to the interstitium, which is important in the
setting of Na+ reabsorption via ENaC and secr tion of K+ via ROMK.
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It prevents paracellular diffusion and back flux of osmolytes into the urine and thus promotes
the formation of steep gradients across the epithelium, which are necessary to drive electrolyte-free
water reabsorption.
Future research will be needed to elucidate further the precise mechanisms that regulate TJ
properties and that mediate crosstalk between paracellular and transcellular transport processes and
how these processes relate to renal pathophysiology.
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Cap1 Channel-activating protease 1
Cldn Claudin
Cl- Chloride
ENaC Epithelial sodium channel
Grhl2 Grainyhead-like 2
K+ Potassium
KLHL3 Kelch-like protein 3
MDCK Madin-Darby Canine Kidney
mIMCD3 Mouse inner medullary collecting duct
Na+ Sodium
NCC Na+ Cl− cotransporter
PHA-II Pseudohypoaldosteronism type II (also known as Gordon’s syndrome)
ROMK Renal outer medullary potassium channel
TER Transepithelial resistance
TJ Tight junction
V2R Vasopressin type 2 receptor
WNK4 With no lysine kinases 4
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